Black Diamond Therapeutics Inc
NASDAQ:BDTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
C
|
CoreCivic Inc
F:PSRA
|
US |
|
C
|
Cleveland-Cliffs Inc
XETRA:CVA
|
US |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
Fuelcell Energy Inc
NASDAQ:FCEL
|
US |
Wall St Price Targets
BDTX Price Targets Summary
Black Diamond Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BDTX is 10.05 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BDTX's stock price target?
Price Target
10.05
USD
According to Wall Street analysts, the average 1-year price target for BDTX is 10.05 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Black Diamond Therapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Operating Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
39%
The compound annual growth rate for Operating Income over the next 8 years is 39%.
What is the Net Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
33%
The compound annual growth rate for Net Income over the next 8 years is 33%.
